| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| R Schlösser, J D Brodie, S L Dewey, D Alexoff, G J Wang, J S Fowler, N Volkow, J Logan, A P Wol. Long-term stability of neurotransmitter activity investigated with 11C-raclopride PET. Synapse (New York, N.Y.). vol 28. issue 1. 1998-01-20. PMID:9414019. |
11c-raclopride pet, which has been shown to be sensitive to changes in endogenous dopamine and has a high short-term test-retest reliability, can be used to investigate different regulatory states of the dopaminergic system with respect to psychiatric diseases and pharmacological influences. |
1998-01-20 |
2023-08-12 |
human |
| M J Guerra, I Liste, J L Labandeira-Garci. Interaction between the serotonergic, dopaminergic, and glutamatergic systems in fenfluramine-induced Fos expression in striatal neurons. Synapse (New York, N.Y.). vol 28. issue 1. 1998-01-20. PMID:9414020. |
in this work, the effects of fe on the major striatal afferent systems, and the possible interactions of these systems in fe-induced striatal expression of fos, were studied by lesion of the serotonergic and/or dopaminergic system and administration of nmda glutamate (mk-801) or d1 dopamine (sch-23390) receptor antagonists. |
1998-01-20 |
2023-08-12 |
Not clear |
| D Dluze. Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine. Brain research. vol 767. issue 2. 1998-01-15. PMID:9367266. |
various parameters of nigrostriatal dopaminergic function as derived from measurements of dopamine and dihydroxyphenylacetic acid (dopac) concentrations were determined from the 6-ohda lesioned and non-lesioned sides of the corpus striatum in these animals. |
1998-01-15 |
2023-08-12 |
rat |
| M P Gygi, A E Fleckenstein, J W Gibb, G R Hanso. Role of endogenous dopamine in the neurochemical deficits induced by methcathinone. The Journal of pharmacology and experimental therapeutics. vol 283. issue 3. 1998-01-15. PMID:9400010. |
these results indicate that dopaminergic systems are profoundly affected by methcathinone administration and that dopamine likely contributes to the monoaminergic effects of this stimulant. |
1998-01-15 |
2023-08-12 |
rat |
| A P Kouzmenko, A M Pereira, B S Sing. Intronic sequences are involved in neural targeting of human dopamine transporter gene expression. Biochemical and biophysical research communications. vol 240. issue 3. 1998-01-13. PMID:9398650. |
dopamine transporter (dat) plays a key role in terminating synaptic dopaminergic transmission. |
1998-01-13 |
2023-08-12 |
human |
| P Terry, J L Kat. Dopaminergic mediation of the discriminative stimulus effects of bupropion in rats. Psychopharmacology. vol 134. issue 2. 1998-01-09. PMID:9399385. |
the results demonstrate strong similarities with those obtained using other dopamine uptake inhibitors as training drugs, and support the view that the behavioural effects of bupropion are primarily mediated by dopaminergic mechanisms. |
1998-01-09 |
2023-08-12 |
rat |
| A C Okkens, H S Kooistra, S J Dieleman, M M Bever. Dopamine agonistic effects as opposed to prolactin concentrations in plasma as the influencing factor on the duration of anoestrus in bitches. Journal of reproduction and fertility. Supplement. vol 51. 1998-01-09. PMID:9404271. |
as the plasma concentrations of prolactin were similar during metergoline and bromocriptine treatment, and the anoestrous period was shortened during bromocriptine treatment, but not during metergoline treatment, these results suggest that the induction of oestrus by dopamine agonists is not initiated by suppression of prolactin secretion, but by other direct or indirect dopaminergic effects. |
1998-01-09 |
2023-08-12 |
Not clear |
| A Ricci, E Bronzetti, P Mulatero, M Schena, F Veglio, F Ament. Dopamine D3 receptor in peripheral mononuclear cells of essential hypertensives. Hypertension (Dallas, Tex. : 1979). vol 30. issue 6. 1998-01-08. PMID:9403584. |
the increased density of peripheral mononuclear cell dopamine d3 receptor in hypertension as well as in parkinson's disease may represent an upregulation mechanism consequent to impaired dopaminergic function. |
1998-01-08 |
2023-08-12 |
human |
| A Ricci, E Bronzetti, P Mulatero, M Schena, F Veglio, F Ament. Dopamine D3 receptor in peripheral mononuclear cells of essential hypertensives. Hypertension (Dallas, Tex. : 1979). vol 30. issue 6. 1998-01-08. PMID:9403584. |
in view of the difficulty in identifying markers of peripheral dopamine function, analysis of dopamine d3 receptor in peripheral mononuclear cells may help evaluate whether the dopaminergic system is involved in hypertension. |
1998-01-08 |
2023-08-12 |
human |
| A Ho, M Blu. Regulation of astroglial-derived dopaminergic neurotrophic factors by interleukin-1 beta in the striatum of young and middle-aged mice. Experimental neurology. vol 148. issue 1. 1998-01-07. PMID:9398477. |
this suggests that bfgf may be the putative endogenous dopaminergic neurotrophic factor mediating lesion-induced plasticity of dopamine neurons. |
1998-01-07 |
2023-08-12 |
mouse |
| G J Sengstock, N H Zawia, C W Olanow, A J Dunn, G W Arendas. Intranigral iron infusion in the rat. Acute elevations in nigral lipid peroxidation and striatal dopaminergic markers with ensuing nigral degeneration. Biological trace element research. vol 58. issue 3. 1998-01-07. PMID:9403131. |
similarly, striatal dopamine turnover was acutely elevated, suggesting damage to dopaminergic neurons, which was confirmed histologically. |
1998-01-07 |
2023-08-12 |
rat |
| E Koutsilieri, M E Götz, S Sopper, U Sauer, M Demuth, V ter Meulen, P Riedere. Regulation of glutathione and cell toxicity following exposure to neurotropic substances and human immunodeficiency virus-1 in vitro. Journal of neurovirology. vol 3. issue 5. 1997-12-30. PMID:9372455. |
effects were compared to treatment with dopamine itself and a typical dopaminergic drug used pharmaceutically, selegiline. |
1997-12-30 |
2023-08-12 |
human |
| L Ferraro, W T O'Connor, T Antonelli, K Fuxe, S Tanganell. Differential effects of intrastriatal neurotensin(1-13) and neurotensin(8-13) on striatal dopamine and pallidal GABA release. A dual-probe microdialysis study in the awake rat. The European journal of neuroscience. vol 9. issue 9. 1997-12-23. PMID:9383206. |
these results suggest that in the neostriatum the neurotensin receptor located postsynaptically on the striatopallidal gaba neurons seems to differ from the neurotensin receptor located on dopaminergic terminals, as indicated by the relative lack of effect of nt(8-13) on striatal dopamine release. |
1997-12-23 |
2023-08-12 |
rat |
| J H Meador-Woodruff, V Haroutunian, P Powchik, M Davidson, K L Davis, S J Watso. Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia. Archives of general psychiatry. vol 54. issue 12. 1997-12-23. PMID:9400344. |
the identification of novel subtypes of the dopamine receptors has renewed interest in the involvement of dopaminergic mechanisms in schizophrenia. |
1997-12-23 |
2023-08-12 |
Not clear |
| K Shichijo, Y Sakurai-Yamashita, I Sekine, K Taniyam. Neuronal release of endogenous dopamine from corpus of guinea pig stomach. The American journal of physiology. vol 273. issue 5. 1997-12-17. PMID:9374701. |
these results indicate that dopamine is physiologically released from neurons and from possible dopaminergic nerve terminals and regulates cholinergic neuronal activity in the corpus of guinea pig stomach. |
1997-12-17 |
2023-08-12 |
Not clear |
| J T Guimarães, M A Vieira-Coelho, M P Serrão, P Soares-da-Silv. Opossum kidney (OK) cells in culture synthesize and degrade the natriuretic hormone dopamine: a comparison with rat renal tubular cells. The international journal of biochemistry & cell biology. vol 29. issue 4. 1997-12-09. PMID:9363646. |
to explore further the usefulness of opossum kidney (ok) cells in the study of renal dopaminergic physiology, we have undertaken the study of aromatic l-amino acid decarboxylase (aaad), catechol-o-methyltransferase (comt) and type a and b monoamine oxidase (mao-a and mao-b), the main enzymes involved in the synthesis and degradation of dopamine. |
1997-12-09 |
2023-08-12 |
rat |
| J W Gibb, L Bush, G R Hanso. Exacerbation of methamphetamine-induced neurochemical deficits by melatonin. The Journal of pharmacology and experimental therapeutics. vol 283. issue 2. 1997-12-08. PMID:9353379. |
methamphetamine (meth), administered in large, repeated doses, compromises the dopaminergic and serotonergic systems as indicated by prolonged suppression of tyrosine hydroxylase and tryptophan hydroxylase activity and concurrent decreases in the content of dopamine and 5-hydroxytryptamine. |
1997-12-08 |
2023-08-12 |
rat |
| J W Gibb, L Bush, G R Hanso. Exacerbation of methamphetamine-induced neurochemical deficits by melatonin. The Journal of pharmacology and experimental therapeutics. vol 283. issue 2. 1997-12-08. PMID:9353379. |
because dopamine is necessary for these dopaminergic and serotonergic deficits we postulated that dopamine and/or its reactive metabolites are responsible for these degenerative alterations. |
1997-12-08 |
2023-08-12 |
rat |
| L Teng, P A Crooks, S T Buxton, L P Dwoski. Nicotinic-receptor mediation of S(-)nornicotine-evoked -3H-overflow from rat striatal slices preloaded with -3H-dopamine. The Journal of pharmacology and experimental therapeutics. vol 283. issue 2. 1997-12-08. PMID:9353398. |
taken together, the results suggest that low concentrations of s(-)nornicotine stimulate nicotinic receptors to evoke the release of dopamine from dopaminergic presynaptic terminals. |
1997-12-08 |
2023-08-12 |
rat |
| P Willne. The mesolimbic dopamine system as a target for rapid antidepressant action. International clinical psychopharmacology. vol 12 Suppl 3. 1997-12-04. PMID:9347387. |
chronic treatment with antidepressant drugs produces a variety of changes in dopaminergic neurotransmission, most notably a sensitization of behavioural responses to agonists acting at dopamine d2/d3 receptors within the nucleus accumbens. |
1997-12-04 |
2023-08-12 |
Not clear |